BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 18477732)

  • 1. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clozapine in the treatment of schizophrenia].
    Mark M; Magnezi R; Luxenburg O; Siebzehner M; Shemer J
    Harefuah; 1999 Sep; 137(5-6):185-8, 264, 263. PubMed ID: 10959316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine for refractory schizophrenia: the Illinois experience.
    Buckman RW; Malan RD
    J Clin Psychiatry; 1999; 60 Suppl 1():18-22; discussion 28-30. PubMed ID: 10037166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use patterns for antipsychotic medications in medicaid patients with schizophrenia.
    McCombs JS; Nichol MB; Stimmel GL; Shi J; Smith RR
    J Clin Psychiatry; 1999; 60 Suppl 19():5-11; discussion 12-3. PubMed ID: 10507275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What information do patients with schizophrenia have about their illness and treatment?].
    Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
    Encephale; 2000; 26(5):30-8. PubMed ID: 11192802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clozapine and typical antipsychotic drugs on plasma 5-HT turnover and impulsivity in patients with schizophrenia: a cross-sectional study.
    Dursun SM; Szemis A; Andrews H; Whitaker P; Reveley MA
    J Psychiatry Neurosci; 2000 Sep; 25(4):347-52. PubMed ID: 11022399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypnosedative prescribing in outpatient psychiatry.
    Huthwaite MA; Andersson V; Stanley J; Romans SE
    Int Clin Psychopharmacol; 2013 Jul; 28(4):157-63. PubMed ID: 23680995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of clozapine therapy for elderly patients with refractory primary psychosis.
    Sajatovic M; Jaskiw G; Konicki PE; Jurjus G; Kwon K; Ramirez LF
    Int J Geriatr Psychiatry; 1997 May; 12(5):553-8. PubMed ID: 9193964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.
    Dursun SM; Szemis A; Andrews H; Reveley MA
    J Psychiatry Neurosci; 1999 Nov; 24(5):453-5. PubMed ID: 10586536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathway to clozapine use: a comparison between a patient cohort from New Zealand and a cohort from the United Kingdom.
    Wheeler AJ; Feetam CL; Harrison J
    Clin Drug Investig; 2014 Mar; 34(3):203-11. PubMed ID: 24402882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clozapine on smoking in chronic schizophrenic outpatients.
    George TP; Sernyak MJ; Ziedonis DM; Woods SW
    J Clin Psychiatry; 1995 Aug; 56(8):344-6. PubMed ID: 7635849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clozapine for resistant schizophrenia and characteristics of those responding].
    Talmon Y; Guy N; Wittenberg N
    Harefuah; 1995 Dec; 129(11):451-4, 536. PubMed ID: 8846949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haematological side effects of clozapine: patient characteristics.
    Miller PR; Cutten AE
    N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New vs. old antipsychotics: the Texas experience.
    Reid WH
    J Clin Psychiatry; 1999; 60 Suppl 1():23-5; discussion 28-30. PubMed ID: 10037167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing clozapine treatment.
    Naber D
    J Clin Psychiatry; 1999; 60 Suppl 12():35-8. PubMed ID: 10372609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience with clozapine in Woodbridge Hospital.
    Wong KE; Chong SA; Ngui F; Winslow M; Devan GS; Leong OK; Choo CH
    Singapore Med J; 1997 Aug; 38(8):336-8. PubMed ID: 9364887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic prescribing pathways, polypharmacy, and clozapine use in treatment of schizophrenia.
    Gören JL; Meterko M; Williams S; Young GJ; Baker E; Chou CH; Kilbourne AM; Bauer MS
    Psychiatr Serv; 2013 Jun; 64(6):527-33. PubMed ID: 23450334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clozapine (Leponex) in France].
    Péré JJ; Chaumet-Riffaud PD; Bourdeix I; Bourdain M
    Encephale; 1992 Sep; 18 Spec No 3():427-32. PubMed ID: 1339758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.